ROCKET PHARMACEUTICALS INC (RCKT) Stock Analyst Ratings
USA - NASDAQ:RCKT - US77313F1066 - Common Stock
3.26 USD
+0.07 (+2.19%)
3.2458 USD
-0.01 (-0.44%)
ChartMill assigns a Buy % Consensus number of 76% to RCKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.08. This target is 147.9% above the current price.
RCKT was analyzed by 23 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about RCKT.
In the previous month the buy percentage consensus was at a similar level.
RCKT was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-20 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-08-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-07-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-25 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-07-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-24 | Needham | Maintains | Hold -> Hold |
| 2025-06-17 | UBS | Maintains | Buy -> Buy |
| 2025-06-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-28 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-28 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-28 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-28 | Jefferies | Downgrade | Buy -> Hold |
| 2025-05-27 | Needham | Downgrade | Buy -> Hold |
| 2025-05-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-05-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-12 | BMO Capital | Initiate | Outperform |
| 2025-03-03 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |